Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Enovis CORP entered into Share Purchase Agreement with Emil Holding II S.à r.l. valued at Enterprise value of approximately €800 million: ~€700 million cash plus 1,942,686 shares of Enovis c (effective 2023-09-22).
- Action
- entry
- Agreement
- merger
- Counterparty
- Emil Holding II S.à r.l.
- Value
- Enterprise value of approximately €800 million: ~€700 million cash plus 1,942,686 shares of Enovis c
- Effective
- 2023-09-22
Exact text from the filing
On September 22, 2023, Enovis Corporation (the “Company”) entered into a definitive agreement to acquire LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic company focused on restoring motion through digital innovation and customized hardware.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Enovis CORP entered into Commitment Letter with JPMorgan Chase Bank, N.A., UBS AG Stamford Branch, UBS Securities LLC valued at $800 million senior bridge facility and $400 million senior term loan facility (effective 2023-09-22).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A., UBS AG Stamford Branch, UBS Securities LLC
- Value
- $800 million senior bridge facility and $400 million senior term loan facility
- Effective
- 2023-09-22
Exact text from the filing
In connection with entering into the Purchase Agreement, on September 22, 2023, the Company entered into a commitment letter (the “Commitment Letter”) with JPMorgan Chase Bank, N.A. (“JPMorgan”), UBS AG Stamford Branch (“UBS AG”), and UBS Securities LLC (“UBS Securities”), pursuant to which JPMorgan and UBS AG agreed to provide a new $800 million senior bridge facility (the “Bridge Facility”) for financing the Acquisition.
View on SEC.gov